151 related articles for article (PubMed ID: 37455277)
1. Is There Re-staging Surgery Necessity for Borderline Ovarian Tumors.
Guo LL; Kang XY; Su Y; Liu XY; Wu X; Xie W; Liu YH; Wang CY
Curr Med Sci; 2023 Aug; 43(4):822-830. PubMed ID: 37455277
[TBL] [Abstract][Full Text] [Related]
2. New Pointers for Surgical Staging of Borderline Ovarian Tumors.
Bendifallah S; Nikpayam M; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
Ann Surg Oncol; 2016 Feb; 23(2):443-9. PubMed ID: 26442919
[TBL] [Abstract][Full Text] [Related]
3. Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.
Gokcu M; Gungorduk K; Aşıcıoğlu O; Çetinkaya N; Güngör T; Pakay G; Cüylan ZF; Toptaş T; Özyurt R; Ağaçayak E; Ozdemir A; Erol O; Turan A; Gülseren V; İcen MS; Şenol T; Güraslan H; Yücesoy B; Sahbaz A; Gungorduk O; Besimoğlu B; Pakay K; Temizkan O; Sancı M; Şimşek T; Meydanlı MM; Harma M; Yaşar L; Boran B; Uysal AD; Karateke A
J Ovarian Res; 2016 Oct; 9(1):66. PubMed ID: 27756415
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
5. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
6. The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors.
Kristensen GS; Schledermann D; Mogensen O; Jochumsen KM
Int J Gynecol Cancer; 2014 Jun; 24(5):874-9. PubMed ID: 24844221
[TBL] [Abstract][Full Text] [Related]
7. Recurrence characteristics and clinicopathological results of borderline ovarian tumors.
Niu L; Tian H; Xu Y; Cao J; Zhang X; Zhang J; Hou J; Lv W; Wang J; Xin L; Dong X; Xu T; Nan Y; Wei H; Chai X; Li N; Ni Y; Shang Y; Zhang L; Zhao Y
BMC Womens Health; 2021 Mar; 21(1):134. PubMed ID: 33789656
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
[TBL] [Abstract][Full Text] [Related]
9. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
10. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
11. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
[TBL] [Abstract][Full Text] [Related]
12. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
13. The Evaluation of Risk Factors Associated With Relapse and Recurrence of Borderline Ovarian Tumors With Long-Term Follow-up.
Sobiczewski P; Kupryjanczyk J; Michalski W; Śpiewankiewicz B
Int J Gynecol Cancer; 2016 Jul; 26(6):1053-61. PubMed ID: 27177283
[TBL] [Abstract][Full Text] [Related]
14. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
15. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
[TBL] [Abstract][Full Text] [Related]
17. Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
Guo L; Kang X; Su Y; Liu X; Xie W; Meng S; Liu Y; Wang W; Wang C
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():107-113. PubMed ID: 38422803
[TBL] [Abstract][Full Text] [Related]
18. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
[TBL] [Abstract][Full Text] [Related]
19. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
Int J Gynecol Cancer; 2022 Apr; 32(4):525-531. PubMed ID: 34969829
[TBL] [Abstract][Full Text] [Related]
20. Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
Zilliox M; Lecointre L; Azais H; Ballester M; Bendifallah S; Bolze PA; Bourdel N; Bricou A; Canlorbe G; Carcopino X; Chauvet P; Collinet P; Coutant C; Dabi Y; Dion L; Gauthier T; Graesslin O; Huchon C; Koskas M; Lavoue V; Mezzadri M; Mimoun C; Ouldamer L; Raimond E; Touboul C; Lapointe M; Akladios C
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():412-418. PubMed ID: 33296755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
